Furthermore, the two antibodies have been associated with SARS-CoV-2-infections: In a small study of 35 SARS-CoV-2 patients, de Santis et al. reported the occurrence of NXP2 (n = 3) and MDA5 antibodies (n = 1). This evidence concerns the gene IFIH1 and COVID-19.